STOCK TITAN

CMPS director files Form 3 showing zero beneficial ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

COMPASS Pathways plc (CMPS) reported an insider ownership update. Director Jeffrey M. Jonas filed a Form 3, the initial statement of beneficial ownership, with an event date of 10/29/2025. The filing states that no securities are beneficially owned. The document was signed by Meredith Prithviraj under a power of attorney for Jeffrey M. Jonas, referencing Exhibit 24.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
JONAS JEFFREY M

(Last) (First) (Middle)
C/O COMPASS PATHWAYS PLC
33 BROADWICK STREET

(Street)
LONDON X0 W1F 0DQ

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/29/2025
3. Issuer Name and Ticker or Trading Symbol
COMPASS Pathways plc [ CMPS ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney
No securities are beneficially owned.
/s/ Meredith Prithviraj by Power of Attorney for Jeffrey M. Jonas 10/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did COMPASS Pathways (CMPS) disclose in this filing?

A Form 3 initial beneficial ownership statement by Director Jeffrey M. Jonas stating no securities are beneficially owned.

What is the event date on the CMPS Form 3?

The event date is 10/29/2025.

Who is the reporting person on this CMPS Form 3?

The reporting person is Jeffrey M. Jonas, identified as a Director.

Does the CMPS Form 3 show any CMPS shares owned?

No. The remarks state No securities are beneficially owned.

Who signed the Form 3 for CMPS?

It was signed by Meredith Prithviraj by Power of Attorney for Jeffrey M. Jonas, referencing Exhibit 24.

Is this Form 3 filed by one or multiple reporting persons?

It is filed by one reporting person.
Compass Pathways Plc

NASDAQ:CMPS

CMPS Rankings

CMPS Latest News

CMPS Latest SEC Filings

CMPS Stock Data

647.15M
84.38M
13.3%
55.64%
8.1%
Medical Care Facilities
Pharmaceutical Preparations
Link
United Kingdom
CHESIRE